BEAMing DNA Detection for Rare Mutation Quantification
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Current methods for detecting subtle and rare differences in nucleic acid molecules, particularly in cancer diagnostics, face challenges in sensitivity, specificity, and the ability to quantify mutant DNA sequences amidst a large excess of normal sequences, leading to inconsistent results and limited detection of early-stage cancers.
Innovation Solution
The BEAMing method involves amplifying DNA molecules using high fidelity polymerases, forming microemulsions with reagent beads, and employing single base extension and rolling circle amplification to generate beads with multiple copies of amplified sequences, enabling precise quantification and detection of rare variants through flow cytometry and sequencing.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Measurement precision
If conventional DNA detection methods are used to detect mutant DNA in circulating samples, then the detection can be performed with standard techniques, but the sensitivity is insufficient to detect rare mutant sequences amidst large excess of normal sequences
Solution Approach 1:
The patent segments the detection process into distinct functional modules: (1) emulsion formation to isolate individual DNA molecules in separate aqueous compartments, (2) PCR amplification within each emulsion droplet to generate bead-bound amplicons, (3) bead separation and washing to remove unbound material, and (4) detection of bead-bound DNA. This segmentation enables highly sensitive detection of rare mutant sequences by preventing cross-contamination and allowing independent amplification of each template molecule.
Solution Approach 2:
The patent introduces magnetic beads as an intermediary carrier that binds to PCR amplicons and enables manipulation, separation, and detection of amplified DNA. The beads serve as a physical mediator between the molecular biology reactions and the detection system, allowing for magnetic separation of bead-bound DNA from free DNA in solution, thereby enhancing detection sensitivity and signal-to-noise ratio.
2Measurement precision
If multiple amplification steps are performed to increase the number of DNA copies for detection, then the detection sensitivity improves, but the risk of introducing amplification errors increases
Solution Approach 1:
The patent performs preliminary high-fidelity PCR amplification within isolated emulsion droplets before bead binding and detection. By conducting the amplification step in controlled, compartmentalized environments with high-fidelity polymerases, the method generates accurate amplicon copies early in the process, minimizing the propagation of errors through subsequent steps.
Solution Approach 2:
The patent employs high-fidelity DNA polymerases with proofreading activity that have significantly lower error rates compared to standard polymerases. This parameter change in enzyme selection reduces the mutation rate during amplification, allowing multiple rounds of PCR to be performed while maintaining sequence accuracy and reliability of the detected mutant sequences.
3Adaptability or versatility
If the fraction of mutant DNA in circulating samples is very low, then the test can be applied to early-stage cancer detection, but the ability to distinguish mutant from normal sequences becomes extremely difficult
Solution Approach 1:
The patent segments the DNA population into individual molecules, each isolated in separate emulsion droplets and subsequently amplified on individual beads. This segmentation allows each mutant DNA molecule to be independently amplified and detected, enabling the discrimination of even single mutant sequences from overwhelming backgrounds of normal sequences through flow cytometric analysis of bead populations.
Solution Approach 2:
The patent replaces traditional mechanical separation and analysis methods with flow cytometry-based detection of magnetically separated beads. This substitution enables highly sensitive discrimination of mutant sequences by detecting fluorescent signals from beads bound to amplified DNA, allowing detection of mutant fractions as low as 1 in 10,000 or更低 concentrations.
Applied Scientific Principles
This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.
Function Achieved in This Case
This approach significantly enhances the sensitivity and accuracy of detecting and quantifying rare nucleic acid differences, allowing for the detection of mutant DNA in early-stage cancers and providing robust signals with high signal-to-noise ratios, thereby improving cancer diagnosis and monitoring.
Implementation Method 1
A region of analyte DNA molecules is amplified using a high fidelity DNA polymerase to form a set of first amplicons
Implementation Method 2
Microemulsions comprising the first amplicons and reagent beads are formed
Implementation Method 3
The second amplicons are amplified using rolling circle amplification to form third amplicons
Data Source
AI summary
Improvements on the basic method used for BEAMing increase sensitivity and increase the signal-to-noise ratio. The improvements have permitted the determination of intrinsic error rates of various DNA polymerases and have permitted the detection of rare and subtle mutations in DNA isolated from plasma of cancer patients.